NEW YORK (GenomeWeb) – An assay from Quidel to detect and differentiate respiratory syncytial virus and human metapneumovirus has received marketing clearance from the US Food and Drug Administration.

The Solana RSV + hMPV assay detects viral RNA from nasal and nasopharyngeal swabs and runs on the firm's Solana molecular testing instrument. It requires no upfront extraction of RNA and generates an accurate result in approximately 45 minutes, according to the firm.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.